Barbell Medicine Podcast

In this free preview of the March 2026 Direct Line AMA. Drs. Feigenbaum and Baraki cover: VO2 max versus cardiorespiratory fitness for longevity (are Peter Attia’s targets evidence-based? — with Goodhart’s Law and the JAMA evidence), what GLP-1 medications actually cost now via manufacturer programs ($149–449/month), and whether 7,000–10,000 daily steps actually meet the bar for cardiovascular training.

Full episode for Barbell Medicine Plus subscribers at https://barbellmedicine.supercast.com/

Timestamps:
0:00 — Introduction
3:26 — VO2 Max vs. Cardiorespiratory Fitness for Longevity
14:11 — GLP-1 Costs: What you should actually be paying now
21:43 — Is Walking Enough for Cardiovascular Health?

Next Steps:

For evidence-based resistance training programs: barbellmedicine.com/training-programs

For individualized training consultation: barbellmedicine.com/coaching

Explore our full library of articles on health and performance: barbellmedicine.com/resources

To consult with Drs. Baraki or Feigenbaum email us at [email protected]

Resources:

JAMA Network Open — Cardiorespiratory Fitness & Long-term Mortality (Mandsager et al.) — Exercise capacity (METs) and longevity — the foundational CRF/mortality study cited in the episode https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
JAMA — Blair et al. — Physical fitness and all-cause mortality: a prospective study of healthy men and women https://jamanetwork.com/journals/jama/fullarticle/379243
Barbell Medicine Vital Five — Multi-modal CRF benchmarks and longevity targets https://www.barbellmedicine.com/vital-5-action-plan/
Lilly Direct — Zepbound (tirzepatide) — Manufacturer direct program ($299–449/month) https://www.lillydirect.com/zepbound
NovoCare — Wegovy (semaglutide) — Manufacturer savings program ($149–349/month) https://www.novocare.com/patient/medicines/wegovy.html
Orforglipron — Eli Lilly oral GLP-1 — What to know about orforglipron (small-molecule oral GLP-1 agonist, pending FDA approval) https://www.lilly.com/news/stories/what-to-know-about-orforglipron

Our Sponsors:
* Check out Factor: https://factormeals.com/bbm50off
* Check out Quince: https://quince.com/BBM

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

You can have a completely normal BMI and be on your way to cardiovascular disease, type 2 diabetes, and metabolic syndrome without triggering a single alert on a standard health screening. The fat that predicts metabolic risk most accurately isn't the fat your scale or your doctor is tracking. Dr. Jordan Feigenbaum breaks down the science of visceral fat — what it is, how it causes disease, how to measure it correctly at home for free, and what the evidence actually shows about exercise, GLP-1 medications, and testosterone.

Timestamps:

00:00:00 Cold Open: The Visceral Fat Finding
00:00:49 The Scale Problem — What Body Weight Actually Measures
00:03:50 What Is Visceral Fat — and Why It's Not Just "Belly Fat"
00:05:04 Three Competing Theories: How Visceral Fat Actually Causes Disease
00:08:35 Adipokines: PAI-1, Angiotensinogen, and What Happens When Adiponectin Drops
00:09:52 How to Measure: Three Sites That Don't Give the Same Number
00:14:30 Clinical Thresholds, Ethnic Adjustments, and the Waist-to-Height Ratio
00:15:45 The Weight-to-Waist Ratio: Tracking the Quality of Your Fat Loss
00:19:20 Sleep, Cortisol, and Why the Hormonal Environment Has to Support the Work
00:21:24 Why Exercise Reduces Visceral Fat 6× More Than Diet Alone
00:22:02 Mechanism 1 — Beta-3 Adrenergic Receptors and Preferential Visceral Fat Mobilization
00:24:10 Mechanism 2 — Myokines: The Fat-Burning Signal Only Contracting Muscle Can Send
00:26:21 GLP-1 Agonists and Body Composition: What the Clinical Trials Actually Show
00:28:05 DXA's Blind Spot: Myosteatosis, Glycogen, and Why Lean Mass Numbers Are Inflated
00:30:10 SEMALEAN, the BELIEVE Trial, and the 1-in-10 Reality of Long-Term Lifestyle Programs
00:33:15 Testosterone, Visceral Fat, and the Aromatase Feed-Forward Loop
00:36:05 Three Testosterone Ranges: Deficient, Eugonadal, and Supraphysiological
00:38:05 The Bhasin 4-Group Study — and Why AAS Are a Class, Not a Synonym for TRT
00:39:33 Tesamorelin: The GHRH Analogue That Selectively Targets Visceral Fat
00:40:53 Practical Framework: What to Measure, When, and What to Do
00:43:20 Key Takeaways

Next Steps

For evidence-based resistance training programs: barbellmedicine.com/training-programs
For individualized training consultation: barbellmedicine.com/coaching
Explore our full library of articles on health and performance: barbellmedicine.com/resources
To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
To consult with Drs. Baraki or Feigenbaum email us at [email protected]
Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/

Resources:

https://pubmed.ncbi.nlm.nih.gov/11502820/
https://pubmed.ncbi.nlm.nih.gov/33567185/
https://pubmed.ncbi.nlm.nih.gov/35658024/
https://pubmed.ncbi.nlm.nih.gov/40318682/
https://pubmed.ncbi.nlm.nih.gov/41068996/
https://pubmed.ncbi.nlm.nih.gov/41772149/
https://pubmed.ncbi.nlm.nih.gov/23944298/
https://pubmed.ncbi.nlm.nih.gov/20948519/
https://pubmed.ncbi.nlm.nih.gov/27213481/
https://pubmed.ncbi.nlm.nih.gov/23303913/

Our Sponsors:
* Check out Factor: https://factormeals.com/bbm50off
* Check out Quince: https://quince.com/BBM

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

A fit, healthy 39-year-old was nearly sent for a liver biopsy. The cause? Was it that he went to the gym before every blood draw or because his supplement was throwing his labs off?. Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the blind spot that sends thousands of healthy athletes down an expensive, potentially unnecessary diagnostic rabbit hole every year.
Timestamps:
00:01:09  Introducing the Case
00:03:44  How to Read a Liver Panel: ALT, AST, GGT, Alk Phos, Albumin Explained
00:10:50  What Is GGT and Why Does It Matter Clinically?
00:16:38  Why Exercise, Protein, and Creatine Aren't on the Differential (Yet)
00:17:35  The Workup: Hepatitis Panels, Abdominal Ultrasound, and More
00:19:42  Second Set of Labs — The Mystery Deepens
00:25:25  Updated Differential: What's Still on the List?
00:27:08  The Labs Normalize — A Critical Clue Appears
00:31:40  The Reveal: Exercise Was the Cause All Along
00:32:18  The Mechanism: How Exercise Elevates 'Liver' Enzymes
00:32:54  Point 1 — ALT & AST Are Not Exclusively Liver Enzymes
00:33:49  Point 2 — It's Unavoidable: 100% of Lifters Are Affected
00:36:02  Point 3 — It Takes 10–12 Days to Normalize
00:37:00  Point 4 — It's Mostly Harmless
00:38:27  56% of Physicians Miss This Diagnosis
00:38:48  Why Clinicians Overlook Exercise History
00:44:01  Point 5 — GGT as the Differentiator (And Its Limits)
00:46:42  Why Alkaline Phosphatase Also Rises Post-Workout
00:48:51  The Cost of Missing Lifestyle Context: Over- and Under-Diagnosis
00:53:29  What to Say to Your Doctor: 3 Patient Scripts
00:59:31  5 Key Takeaways
01:00:25  Final Advice from Dr. Baraki 

Next Steps
For evidence-based resistance training programs: barbellmedicine.com/training-programs
For individualized training consultation: barbellmedicine.com/coaching
Explore our full library of articles on health and performance: barbellmedicine.com/resources
To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
To consult with Drs. Baraki or Feigenbaum email us at [email protected] 
Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/

Resources:
Case: https://pubmed.ncbi.nlm.nih.gov/37025214/
https://pubmed.ncbi.nlm.nih.gov/29059178/ 
https://pmc.ncbi.nlm.nih.gov/articles/PMC7438350/
https://pubmed.ncbi.nlm.nih.gov/18557801/
https://pubmed.ncbi.nlm.nih.gov/19209234/
https://pubmed.ncbi.nlm.nih.gov/11476029/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11165564/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12460594/ 
https://pmc.ncbi.nlm.nih.gov/articles/PMC2291230/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11319523/ 
https://pmc.ncbi.nlm.nih.gov/articles/PMC3936967/
https://pmc.ncbi.nlm.nih.gov/articles/PMC12188904/
https://pmc.ncbi.nlm.nih.gov/articles/PMC7969109/
https://pmc.ncbi.nlm.nih.gov/articles/PMC11498664/
https://pmc.ncbi.nlm.nih.gov/articles/PMC3104191/

Our Sponsors:
* Check out Factor: https://factormeals.com/bbm50off
* Check out Quince: https://quince.com/BBM

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

In this special preview of the Barbell Medicine Plus Direct Line, Dr. Jordan Feigenbaum and Dr. Austin Baraki move past the fitness basics to tackle high-level technical nuances. We dive into the persistent myth of "muscle imbalances" and why your asymmetry might actually be a functional feature of your training.
We also address the "meat" of the cardiovascular debate: is red meat and saturated fat consumption still risky if you are highly active and have a high-fiber diet? Finally, we explore the Dual Intervention Point Model to explain why the body defends its energy stores and how our environment has shifted the biological "set point" for body fat.
Timestamps
00:00 – Barbell Medicine Plus: Special Annual Membership Promotion
01:03 – Muscle Imbalances: A Reliable Predictor of Pain?
03:59 – Acuted vs. Gradually Acquired Asymmetries
08:55 – How Coaches Should Manage "Alignment" Beliefs
11:54 – Is Red Meat Necessary to Limit if You Are Otherwise Healthy?
15:36 – The Role of Substitution: Plant vs. Animal Protein
19:50 – Analyzing the Lean Mass Hyper-Responder (LMHR) Phenotype
26:20 – The Dual Intervention Point Model of Body Fatness
30:26 – Lipostat, Gravistat, and the Regulation of Energy Stores

Next Steps
For evidence-based resistance training programs: barbellmedicine.com/training-programs
For individualized training consultation: barbellmedicine.com/coaching
Explore our full library of articles on health and performance: barbellmedicine.com/resources
To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
To consult with Drs. Baraki or Feigenbaum email us at [email protected] 
Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/ 

Key Takeaways
Asymmetry as a Feature: Human bodies are not naturally symmetrical. In many athletes—such as tennis players, pitchers, or rowers—asymmetry is a functional adaptation to the sport's demands.
The Pathological vs. The Normal: Acutely acquired asymmetries (post-surgery or trauma) require specific clinical attention. Long-standing or gradually acquired asymmetries are rarely the primary driver of pain.
Saturated Fat & The Healthy User Bias: While fit individuals have a lower overall risk profile, elevated LDL and ApoB particles represent a "time-volume" exposure risk that should not be ignored based solely on lifestyle.
The Lean Mass Hyper-Responder (LMHR): We analyze the bold claims surrounding the LMHR phenotype and discuss why mechanistic hypothesizing currently lacks the "hard human outcome receipts" to prove long-term safety.
Body Fat Regulation: The Dual Intervention Point Model suggests the body defends a lower boundary (starvation) and an upper boundary (predation). In the modern environment, the "predation pressure" has vanished, leading to a genetic drift upward in body fat set points.

Our Sponsors:
* Check out Factor: https://factormeals.com/bbm50off
* Check out Quince: https://quince.com/BBM

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy

Most doctors, trainers, and "safety-first" influencers warn that holding your breath while lifting is a dangerous habit that could lead to a stroke or heart failure. By looking back at the 300-year history of the Valsalva maneuver—from a 1704 ear treatment to the "boogeyman" blood pressure studies of the 1980s—we dismantle the myth of the "fragile tube." Discover the science of the "pressurized suit" and why your body is actually designed to handle extreme internal pressure during heavy exertion.

Key Takeaways
The 'Ear Trick' Origins: Originally described in 1704 by Antonio Maria Valsalva as a way to clear middle-ear infections, the maneuver wasn't linked to cardiovascular risk until the 1850s "Weber experiments."
The MacDougall 480/350 Study: Why the finding of massive blood pressure spikes during leg presses may have created a "villain arc" for the Valsalva maneuver in modern medicine.
Transmural Pressure Protection: A blood vessel fails when internal pressure significantly exceeds external support; during a Valsalva, the internal spike is matched by an external "cradle" of intra-thoracic and cerebrospinal fluid pressure.
Reflexive vs. Intentional Bracing: The Valsalva maneuver is a hard-wired reflex that triggers involuntarily at approximately 80% of a maximal voluntary contraction to stabilize the trunk.
Vascular Safety and Stroke Risk: Evidence suggests that for healthy populations, the risk of a vascular "pop" is negligible because the pressure gradient across the vessel wall (transmural pressure) remains stable.
Pregnancy and Fetal Safety: Clinical data on pregnant athletes shows that heavy, braced lifting up to 90% of a 10-rep max does not cause fetal distress or compromised uterine blood flow.
The 'Hissing' Safety Valve: For those prone to lightheadedness or pelvic floor symptoms, using a slow, active exhalation (a hiss) during the concentric phase can help manage pressure transitions.

Timestamps

[00:00] History: From the 1704 Ear Treatise to the Weber Fainting Experiments
[05:26] The 1985 MacDougall Study: Origin of the "480/350" Blood Pressure Boogeyman
[06:22] The Anatomy of a Breath-Hold: The 4 Phases of the Valsalva Maneuver
[12:59] Reflexive Bracing: Why You Can’t Stop Yourself from Holding Your Breath
[28:24] The Pressurized Suit: Transmural Pressure and Vascular Safety
[31:00] The Brain and the Box: CSF Protection and Intracranial Pressure
[35:27] Heart Health: Does Lifting Cause Pathological Heart Thickening?
[41:17] Special Populations: Strokes, Aneurysms, and the 'Pop' Theory
[46:15] The Pelvic Floor: Stress Incontinence and the Weightlifter's Paradox
[49:34] Pregnancy: Monitoring Fetal Heart Rates During Heavy Braced Lifting
[56:42] Contraindications: When is the Valsalva Maneuver Actually Dangerous?

Next Steps

For evidence-based resistance training programs: barbellmedicine.com/training-programs
For individualized training consultation: barbellmedicine.com/coaching
Explore our full library of articles on health and performance: barbellmedicine.com/resources
To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
To consult with Drs. Baraki or Feigenbaum email us at [email protected] 
Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/ 

References
Middle Cerebral Artery and Valsalva
Valsalva During Resistance Training
Valsalva and Force Production and Weight
IAP During Coughing
Lifting Belt’s Effects 
Leg Press
Training and Heart Adaptations
Powerlifter’s Hearts
Valsalva Maneuver and Cerebrovascular Dynamics
RT, VM, and Cerebrovascular Pressures
Women’s Pelvic Floors
Pregnancy and RT and Again
Fetal Heart Rate
Injury Risk
Hernia
SUI Podcast

Our Sponsors:
* Check out Factor: https://factormeals.com/bbm50off
* Check out Quince: https://quince.com/BBM

Advertising Inquiries: https://redcircle.com/brands

Privacy & Opt-Out: https://redcircle.com/privacy